Free Trial

AC Immune (ACIU) News Today

→ After Conviction, More Bad News for Trump (From Paradigm Press) (Ad)
Free ACIU Stock Alerts
$4.77
-0.10 (-2.05%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends
May 31, 2024 | americanbankingnews.com
AC Immune (NASDAQ:ACIU) Coverage Initiated at BTIG Research
May 30, 2024 | americanbankingnews.com
AC Immune SA (NASDAQ:ACIU) Short Interest Up 218.1% in May
May 28, 2024 | marketbeat.com
AC Immune SA (NASDAQ:ACIU) Short Interest Update
AC Immune SA (NASDAQ:ACIU - Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 1,610,000 shares, a growth of 218.1% from the April 30th total of 506,200 shares. Approximately 2.8% of the company's stock are short sold. Based on an average trading volume of 781,200 shares, the days-to-cover ratio is currently 2.1 days.
May 28, 2024 | globenewswire.com
AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024
May 21, 2024 | finance.yahoo.com
Individual investors own 24% of AC Immune SA (NASDAQ:ACIU) shares but private equity firms control 30% of the company
May 16, 2024 | markets.businessinsider.com
Buy Rating Justified by Strategic Partnerships and Promising Pipeline in AC Immune SA
May 16, 2024 | marketbeat.com
FY2028 Earnings Forecast for AC Immune SA Issued By Leerink Partnrs (NASDAQ:ACIU)
AC Immune SA (NASDAQ:ACIU - Free Report) - Equities research analysts at Leerink Partnrs increased their FY2028 earnings estimates for AC Immune in a report issued on Monday, May 13th. Leerink Partnrs analyst M. Goodman now anticipates that the company will earn $0.17 per share for the year, up f
May 15, 2024 | markets.businessinsider.com
Buy Rating Affirmed: AC Immune’s Promising Alzheimer’s Vaccine and Strategic Takeda Partnership
May 15, 2024 | marketbeat.com
Brokers Issue Forecasts for AC Immune SA's FY2025 Earnings (NASDAQ:ACIU)
AC Immune SA (NASDAQ:ACIU - Free Report) - Investment analysts at HC Wainwright reduced their FY2025 EPS estimates for shares of AC Immune in a research report issued to clients and investors on Tuesday, May 14th. HC Wainwright analyst A. Fein now forecasts that the company will earn $0.34 per sh
May 14, 2024 | ft.com
Takeda Pharmaceuticals reaches $2bn deal to develop Alzheimer’s vaccine
May 13, 2024 | msn.com
Alzheimer’s vaccine licensing deal boosts AC Immune
May 13, 2024 | finance.yahoo.com
Sector Update: Health Care Stocks Mixed Late Afternoon
May 13, 2024 | investorplace.com
ACIU Stock Earnings: AC Immune Misses EPS for Q1 2024
May 13, 2024 | investorplace.com
Why Is AC Immune (ACIU) Stock Up 45% Today?
May 13, 2024 | marketwatch.com
AC Immunity Shares Soar on Exclusive License Deal with Takeda
May 13, 2024 | sfgate.com
AC Immune: Q1 Earnings Snapshot
May 13, 2024 | finance.yahoo.com
Takeda Pharmaceutical, AC Immune Agree to Option and Licence Agreement, Including on Alzheimer's Treatment Candidate
May 13, 2024 | globenewswire.com
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 13, 2024 | businesswire.com
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
May 13, 2024 | globenewswire.com
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease
May 9, 2024 | marketbeat.com
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded AC Immune from a "sell" rating to a "hold" rating in a report on Wednesday.
April 27, 2024 | money.usnews.com
AC Immune SA
April 18, 2024 | finance.yahoo.com
AC Immune SA (ACIU)
April 11, 2024 | finance.yahoo.com
We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth
March 20, 2024 | wsj.com
AC Immune S.A.
March 18, 2024 | marketbeat.com
HC Wainwright Reaffirms Buy Rating for AC Immune (NASDAQ:ACIU)
HC Wainwright restated a "buy" rating and set a $16.00 target price on shares of AC Immune in a research report on Friday.
March 15, 2024 | markets.businessinsider.com
Buy Rating for AC Immune SA on Promising Alzheimer’s Vaccine Trial Design and Potential Accelerated Approval
March 15, 2024 | finance.yahoo.com
Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58%
March 14, 2024 | finance.yahoo.com
ACIU Mar 2024 2.500 put
March 14, 2024 | globenewswire.com
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
March 10, 2024 | marketbeat.com
AC Immune (ACIU) to Release Quarterly Earnings on Monday
AC Immune (NASDAQ:ACIU) will be releasing earnings on Monday, March 11, Yahoo Finance reports.
March 8, 2024 | marketbeat.com
Leerink Partnrs Comments on AC Immune SA's Q1 2024 Earnings (NASDAQ:ACIU)
AC Immune SA (NASDAQ:ACIU - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2024 earnings per share (EPS) estimates for shares of AC Immune in a report issued on Wednesday, March 6th. Leerink Partnrs analyst M. Goodman expects that the company will earn ($0.18) per share fo
February 22, 2024 | finanznachrichten.de
AC Immune SA: AC Immune Announces Upcoming Presentations at AD/PD 2024
February 22, 2024 | finance.yahoo.com
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
February 22, 2024 | globenewswire.com
AC Immune Announces Upcoming Presentations at AD/PD™ 2024
February 21, 2024 | insidermonkey.com
5 Little-Known Penny Stocks With Massive Upside Potential
February 20, 2024 | finance.yahoo.com
ACIU May 2024 2.500 call
February 20, 2024 | finance.yahoo.com
ACIU Aug 2024 2.500 call
February 14, 2024 | marketbeat.com
Short Interest in AC Immune SA (NASDAQ:ACIU) Decreases By 14.1%
AC Immune SA (NASDAQ:ACIU - Get Free Report) saw a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 480,600 shares, a decrease of 14.1% from the January 15th total of 559,300 shares. Based on an average daily trading volume, of 127,500 shares, the short-interest ratio is presently 3.8 days. Currently, 0.9% of the company's stock are sold short.
February 13, 2024 | investing.com
AC Immune Ltd (ACIU)
February 1, 2024 | markets.businessinsider.com
Buy Rating Affirmed for AC Immune SA Amid Promising Immunotherapy Program Developments
January 30, 2024 | finance.yahoo.com
Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
January 22, 2024 | finanznachrichten.de
AC Immune SA: AC Immune to Regain Global Rights to Crenezumab and Semorinemab
January 22, 2024 | finance.yahoo.com
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
January 18, 2024 | finance.yahoo.com
AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
January 8, 2024 | finance.yahoo.com
5 Small-Cap Stocks to Play the January Effect
January 3, 2024 | msn.com
AC Immune issues updates on Phase 2 studies, cash runway
January 3, 2024 | finance.yahoo.com
AC Immune (ACIU) Upgraded to Buy: Here's Why
January 3, 2024 | finance.yahoo.com
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
December 15, 2023 | msn.com
AC Immune Alzheimer's drug advanced into Phase 2b testing
Get AC Immune News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter.

A New Generation of Billionaires Is About to Be Created (Ad)

On June 30, AI will hit a tipping-point… $15.7 trillion of wealth is at stake. As many as 800 million jobs are caught in AI’s crosshairs…

Click here for details. 

ACIU Media Mentions By Week

ACIU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACIU
News Sentiment
▼
1.18

0.73
▲
Average
Medical
News Sentiment

ACIU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACIU Articles
This Week
▼
0

1
▲
ACIU Articles
Average Week

Get AC Immune News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACIU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ACIU) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Shocking $16T Elon Musk Crypto Leak
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...
Crypto 101 Media | Sponsored
Nvidia has Apple and Microsoft within striking range
A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. W...
Weiss Ratings | Sponsored